Decreased shedding dipeptidyl peptidase 4 from membrane in Hashimoto's thyroiditis
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 81, 106315
- https://doi.org/10.1016/j.intimp.2020.106315
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81870593, 81600663)
- Natural Science Foundation of Shandong Province (ZR2018MH008)
This publication has 23 references indexed in Scilit:
- Lymphocytes are a major source of circulating soluble dipeptidyl peptidase 4Clinical and Experimental Immunology, 2018
- Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseasesMicrobial Pathogenesis, 2018
- Anti-CD26 autoantibodies are involved in rheumatoid arthritis and show potential clinical interestClinical Biochemistry, 2017
- Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune systemClinical and Experimental Immunology, 2016
- Immunogenetics of autoimmune thyroid diseases: A comprehensive reviewJournal of Autoimmunity, 2015
- Hashimoto thyroiditis: Clinical and diagnostic criteriaAutoimmunity Reviews, 2014
- Impairment of GLP1‐induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemiaDiabetes, Obesity and Metabolism, 2012
- The incidence and prevalence of thyroid autoimmunityEndocrine, 2012
- Dipeptidyl peptidase IV and related enzymes in cell biology and liver disordersClinical Science, 2005
- CD26: A Multifunctional Integral Membrane and Secreted Protein of Activated LymphocytesScandinavian Journal of Immunology, 2001